Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
QuintilesIMS
Baxter
Chubb
Accenture
Deloitte
Merck
Medtronic
UBS

Generated: August 17, 2018

DrugPatentWatch Database Preview

Ajanta Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for AJANTA PHARMA, and what generic and branded alternatives to AJANTA PHARMA drugs are available?

AJANTA PHARMA has twenty-three approved drugs.

There is one tentative approval on AJANTA PHARMA drugs.

Summary for Ajanta Pharma
US Patents:0
Tradenames:19
Ingredients:19
NDAs:23
Patent Litigation for Ajanta Pharma: See patent lawsuits for Ajanta Pharma

Drugs and US Patents for Ajanta Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ajanta Pharma Ltd LANSOPRAZOLE lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 203957-002 Oct 14, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Ajanta Pharma Ltd MONTELUKAST SODIUM montelukast sodium TABLET, CHEWABLE;ORAL 203328-001 Jul 31, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Ajanta Pharma Ltd DULOXETINE HYDROCHLORIDE duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 208706-002 Jan 6, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Ajanta Pharma Ltd OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 204320-001 May 30, 2017 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
Boehringer Ingelheim
Chinese Patent Office
Mallinckrodt
Covington
Federal Trade Commission
UBS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.